These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15478008)

  • 1. American Chemical Society--228th National Meeting. Gamma-secretase inhibitors. 22-26 August 2004, Philadelphia, PA, USA.
    Paterson D; Ognjenovic M
    IDrugs; 2004 Oct; 7(10):895-7. PubMed ID: 15478008
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.
    Pollack SJ; Lewis H
    Curr Opin Investig Drugs; 2005 Jan; 6(1):35-47. PubMed ID: 15675602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential novel targets for Alzheimer pharmacotherapy: I. Secretases.
    Maiorini AF; Gaunt MJ; Jacobsen TM; McKay AE; Waldman LD; Raffa RB
    J Clin Pharm Ther; 2002 Jun; 27(3):169-83. PubMed ID: 12081630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenchylamine sulfonamide inhibitors of amyloid beta peptide production by the gamma-secretase proteolytic pathway: potential small-molecule therapeutic agents for the treatment of Alzheimer's disease.
    Rishton GM; Retz DM; Tempest PA; Novotny J; Kahn S; Treanor JJ; Lile JD; Citron M
    J Med Chem; 2000 Jun; 43(12):2297-9. PubMed ID: 10882355
    [No Abstract]   [Full Text] [Related]  

  • 5. A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity.
    Wolfe MS; Citron M; Diehl TS; Xia W; Donkor IO; Selkoe DJ
    J Med Chem; 1998 Jan; 41(1):6-9. PubMed ID: 9438016
    [No Abstract]   [Full Text] [Related]  

  • 6. Gamma-secretase inhibitors and Alzheimer's disease.
    Roberts SB
    Adv Drug Deliv Rev; 2002 Dec; 54(12):1579-88. PubMed ID: 12453675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Chemical Society 230th National Meeting. Neurological disorders.
    Ognjenovic M; Perry L
    IDrugs; 2005 Nov; 8(11):887-9. PubMed ID: 16254777
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in the development of gamma-secretase inhibitors.
    Josien H
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):513-25. PubMed ID: 12197309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Substituted gem-cyclohexane sulfone based gamma-secretase inhibitors for Alzheimer's disease: conformational analysis and biological activity.
    Jelley RA; Elliott J; Gibson KR; Harrison T; Beher D; Clarke EE; Lewis HD; Shearman M; Wrigley JD
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3839-42. PubMed ID: 16682202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2,3-Benzodiazepin-1,4-diones as peptidomimetic inhibitors of gamma-secretase.
    Prasad CV; Vig S; Smith DW; Gao Q; Polson CT; Corsa JA; Guss VL; Loo A; Barten DM; Zheng M; Felsenstein KM; Roberts SB
    Bioorg Med Chem Lett; 2004 Jul; 14(13):3535-8. PubMed ID: 15177468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core.
    Lewis SJ; Smith AL; Neduvelil JG; Stevenson GI; Lindon MJ; Jones AB; Shearman MS; Beher D; Clarke E; Best JD; Peachey JE; Harrison T; Castro JL
    Bioorg Med Chem Lett; 2005 Jan; 15(2):373-8. PubMed ID: 15603957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymes point way to potential Alzheimer's therapies.
    Pennisi E
    Science; 1999 Oct; 286(5440):650-1. PubMed ID: 10577210
    [No Abstract]   [Full Text] [Related]  

  • 13. gamma-Secretase inhibitors--from molecular probes to new therapeutics?
    Harrison T; Beher D
    Prog Med Chem; 2003; 41():99-127. PubMed ID: 12774692
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis of tetramic and tetronic acids as beta-secretase inhibitors.
    Larbig G; Schmidt B
    J Comb Chem; 2006; 8(4):480-90. PubMed ID: 16827559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-secretase inhibitors for Alzheimer's disease: balancing efficacy and toxicity.
    Barten DM; Meredith JE; Zaczek R; Houston JG; Albright CF
    Drugs R D; 2006; 7(2):87-97. PubMed ID: 16542055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine. Avoiding unintended toxicity.
    Golde TE; Kukar TL
    Science; 2009 May; 324(5927):603-4. PubMed ID: 19407192
    [No Abstract]   [Full Text] [Related]  

  • 17. Proteinase inhibitors - IBC's Third International Conference. New approaches, new discoveries, new targets.
    Durrance A
    IDrugs; 2004 Feb; 7(2):140-2. PubMed ID: 15057658
    [No Abstract]   [Full Text] [Related]  

  • 18. gamma-Secretase as a target for drug intervention in Alzheimer's disease.
    Harrison T; Churcher I; Beher D
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):709-19. PubMed ID: 15503873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin-1.
    Esler WP; Kimberly WT; Ostaszewski BL; Diehl TS; Moore CL; Tsai JY; Rahmati T; Xia W; Selkoe DJ; Wolfe MS
    Nat Cell Biol; 2000 Jul; 2(7):428-34. PubMed ID: 10878808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memapsin 2 (beta-secretase) as a therapeutic target.
    Hong L; Turner RT; Koelsch G; Ghosh AK; Tang J
    Biochem Soc Trans; 2002 Aug; 30(4):530-4. PubMed ID: 12196130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.